We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
+$18.4M
Cap. Flow
+$63.1M
Cap. Flow %
4.78%
Top 10 Hldgs %
33.66%
Holding
527
New
34
Increased
323
Reduced
125
Closed
25

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$29.1M
2
GLD icon
SPDR Gold Trust
GLD
+$19.8M
3
WMT icon
Walmart Inc
WMT
+$17M
4
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$13.8M
5
AMAT icon
Applied Materials
AMAT
+$4.96M

Top Sells

Rank Stock Value
1
UGL icon
ProShares Ultra Gold
UGL
+$12.5M
2
AZN icon
AstraZeneca
AZN
+$8.14M
3
AVGO icon
Broadcom
AVGO
+$5.93M
4
MSFT icon
Microsoft
MSFT
+$4.33M
5
APH icon
Amphenol
APH
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 35.21%
2 Healthcare 22.82%
3 Communication Services 11.05%
4 Consumer Discretionary 8.42%
5 Consumer Staples 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMLX icon
326
Amylyx Pharmaceuticals
AMLX
$2.6B
$271K 0.02%
19,488
+1,593
+9% +$22.4K
ATAI icon
327
AtaiBeckley Inc
ATAI
$2.68B
$266K 0.02%
+75,255
New +$283K
ZBIO
328
Zenas BioPharma
ZBIO
$1.98B
$264K 0.02%
13,526
+212
+2% +$4.76K
ARDX icon
329
Ardelyx
ARDX
$1.03B
$261K 0.02%
43,521
+3,928
+10% +$26K
CTMX icon
330
CytomX Therapeutics
CTMX
$760M
$259K 0.02%
55,068
+27,459
+99% +$139K
IOVA icon
331
Iovance Biotherapeutics
IOVA
$3.05B
$257K 0.02%
73,106
+8,420
+13% +$26.9K
VIR icon
332
Vir Biotechnology
VIR
$1.52B
$250K 0.02%
27,890
+5,220
+23% +$41.6K
XERS icon
333
Xeris Biopharma Holdings
XERS
$1.55B
$245K 0.02%
42,245
+15,208
+56% +$101K
PGEN icon
334
Precigen
PGEN
$2.45B
$243K 0.02%
62,789
+5,133
+9% +$21.1K
WVE icon
335
Wave Life Sciences
WVE
$1.03B
$242K 0.02%
33,407
-6,335
-16% -$82.5K
VICR icon
336
Vicor
VICR
$10.4B
$242K 0.02%
+1,500
New +$248K
MBX
337
MBX Biosciences
MBX
$3.23B
$238K 0.02%
7,968
-7,349
-48% -$250K
NVAX icon
338
Novavax
NVAX
$1.31B
$235K 0.02%
28,914
+2,435
+9% +$22.1K
HROW icon
339
Harrow
HROW
$1.48B
$232K 0.02%
6,573
+538
+9% +$23.6K
DECK icon
340
Deckers Outdoor
DECK
$12.4B
$227K 0.02%
2,263
-1,645
-42% -$176K
ORIC icon
341
Oric Pharmaceuticals
ORIC
$1.43B
$226K 0.02%
17,809
+1,939
+12% +$22K
RMD icon
342
ResMed
RMD
$32.8B
$224K 0.02%
1,000
– –
BCAX
343
Bicara Therapeutics
BCAX
$1.62B
$224K 0.02%
11,244
+2,317
+26% +$39.9K
GLUE icon
344
Monte Rosa Therapeutics
GLUE
$1.36B
$223K 0.02%
13,530
-5,081
-27% -$97.2K
NVCR icon
345
NovoCure
NVCR
$2.05B
$220K 0.02%
20,194
+1,947
+11% +$24.3K
TSHA icon
346
Taysha Gene Therapies
TSHA
$2.05B
$217K 0.02%
48,609
+3,974
+9% +$18.5K
OLMA icon
347
Olema Pharmaceuticals
OLMA
$913M
$212K 0.02%
14,225
+1,207
+9% +$26.9K
CYD icon
348
China Yuchai International
CYD
$1.76B
$212K 0.02%
5,500
+3,500
+175% +$156K
ALV icon
349
Autoliv
ALV
$8.85B
$210K 0.02%
2,000
– –
PAHC icon
350
Phibro Animal Health
PAHC
$1.37B
$202K 0.02%
3,660
+328
+10% +$15.6K
12 13
14
15 16

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q1 2026 Portfolio in Review

As of Q1 2026, China Universal Asset Management Company held 527 positions worth $1.32B, up 1.4% from $1.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

China Universal Asset Management Company deployed $63.1M of net new capital in Q1 2026, opening 34 new positions and adding to 323 existing holdings. Its largest new stake was TJX Companies: 13,200 shares worth $2.11M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was ProShares Ultra Gold, an estimated $12.5M trimmed.

  • China Universal Asset Management Company's largest Q1 2026 buy was TJX Companies: 13,200 shares worth $2.11M.
  • China Universal Asset Management Company added most to iShares Gold Trust in Q1 2026, an estimated $29.1M increase.
  • China Universal Asset Management Company's biggest Q1 2026 reduction was ProShares Ultra Gold, cutting an estimated $12.5M.
  • China Universal Asset Management Company fully exited ServiceNow in Q1 2026, selling an estimated $2.5M.
  • China Universal Asset Management Company's ten largest holdings make up 34% of its $1.32B portfolio in Q1 2026.
  • China Universal Asset Management Company opened 34 new positions and closed 25 in Q1 2026.
  • China Universal Asset Management Company's portfolio value rose 1.4% quarter-over-quarter to $1.32B.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.